succinylcholine chloride

Generic: succinylcholine chloride

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name succinylcholine chloride
Generic Name succinylcholine chloride
Labeler baxter healthcare corporation
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

succinylcholine chloride dihydrate 20 mg/mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 43066-129
Product ID 43066-129_3b9ee5c1-e92b-4ebe-98d2-d3d6ffe3dd1c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218878
Listing Expiration 2026-12-31
Marketing Start 2024-09-24

Pharmacologic Class

Classes
depolarizing neuromuscular blocker [epc] neuromuscular depolarizing blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43066129
Hyphenated Format 43066-129

Supplemental Identifiers

RxCUI
2598128 2694114
UNII
8L0S1G435E

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name succinylcholine chloride (source: ndc)
Generic Name succinylcholine chloride (source: ndc)
Application Number ANDA218878 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 5 CARTON in 1 CARTON (43066-129-05) / 1 SYRINGE, PLASTIC in 1 CARTON (43066-129-01) / 10 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (1)

43066-129-05 5 CARTON in 1 CARTON (43066-129-05) / 1 SYRINGE, PLASTIC in 1 CARTON (43066-129-01) / 10 mL in 1 SYRINGE, PLASTIC

Ingredients (1)

succinylcholine chloride dihydrate (20 mg/mL)

Linked Drug Pages (1)

SUCCINYLCHOLINE CHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "3b9ee5c1-e92b-4ebe-98d2-d3d6ffe3dd1c", "openfda": {"unii": ["8L0S1G435E"], "rxcui": ["2598128", "2694114"], "spl_set_id": ["30f58922-3c74-4813-ace0-fcd2024acd09"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 CARTON in 1 CARTON (43066-129-05)  / 1 SYRINGE, PLASTIC in 1 CARTON (43066-129-01)  / 10 mL in 1 SYRINGE, PLASTIC", "package_ndc": "43066-129-05", "marketing_start_date": "20240924"}], "brand_name": "SUCCINYLCHOLINE CHLORIDE", "product_id": "43066-129_3b9ee5c1-e92b-4ebe-98d2-d3d6ffe3dd1c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Depolarizing Neuromuscular Blocker [EPC]", "Neuromuscular Depolarizing Blockade [PE]"], "product_ndc": "43066-129", "generic_name": "SUCCINYLCHOLINE CHLORIDE", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SUCCINYLCHOLINE CHLORIDE", "active_ingredients": [{"name": "SUCCINYLCHOLINE CHLORIDE DIHYDRATE", "strength": "20 mg/mL"}], "application_number": "ANDA218878", "marketing_category": "ANDA", "marketing_start_date": "20240924", "listing_expiration_date": "20261231"}